You are here

Article Text

Article menu
Download PDFPDF
Editorial
Why and how to screen for atrial fibrillation

http://dx.doi.org/10.1136/heartjnl-2018-313085

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests LF has served as a consultant or speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Livanova, Medtronic and Novartis.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles